PAUL BUSHDID joined Southern Research to lead its Developmental & Reproductive Toxicology program. Previously, Bushdid spent 13 years at GlaxoSmithKline, where he headed an Investigative Developmental Toxicology group, where his work focused on agents that can cause birth defects or halt pregnancies. Bushdid’s team was also involved in DART assessments of traditional Chinese medicines, study...
Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center.
